Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs

	Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs
Source Publication	CELL PROLIFERATION
	2020
Volume	53 Issue:12 Pages:e12944
	Wu J(吴骏); Zhou Xing; Tan YQ(谭元卿); Wang L(王柳); Li TD(李天达); Li ZW(李仲文); Gao TT(高婷婷); Fan JQ(范佳琪); Guo BJ(郭保杰); Li W(李伟); Hao J(郝捷); Wang Xianguang; Hu BY(胡宝洋)
Document Type	期刊论文
Identifier	http://ir.ioz.ac.cn/handle/000000/14488
Collection	干细胞与生殖生物学国家重点实验室
Recommended Citation GB/T 7714	Wu J,Zhou Xing,Tan YQ,et al. Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs[J]. CELL PROLIFERATION,2020,53(12):e12944.
APA	吴骏.,Zhou Xing.,谭元卿.,王柳.,李天达.,...&胡宝洋.(2020).Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs.CELL PROLIFERATION,53(12),e12944.
MLA	吴骏,et al."Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs".CELL PROLIFERATION 53.12(2020):e12944.

Related Services

Bookmark

Google Scholar

Similar articles in Bing Scholar

Terms of Use

No data!

Social Bookmark/Share

File name:	Phase 1 trial for treatment of COVID-19.pdf
Format:	Adobe PDF

All comments (0)

No comment.

The comment function is only available to registered usersLog In

If you have any objections to this item, please fill out the form below and the administrator will contact you as soon as possible.
Content:
Email：	*
Institution:
Verification Code:	Refresh

Any comments and suggestions are welcomed.
Title:	*
Content:
Email：	*
Verification Code:	Refresh

中国科学院动物研究所机构知识库